Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The 340B Drug Pricing Program allows certain hospitals and clinics to buy medications given to outpatients at a discount, ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Such companies can be wonderful options for income-seeking investments. If you're in the market for that combo, let's ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...

U.S. hospitals and generic drugmakers urge President Trump to exempt medical goods from new tariffs on Chinese imports. They warn that these tariffs could cause medicine shortages and increase prices.

State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a median 4% at the start of this year. The modest size of the annual ...